Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model.
Oncoimmunology. 2020 Sep 20;9(1):1817653. doi: 10.1080/2162402X.2020.1817653.
Oncoimmunology. 2020.
PMID: 33457098
Free PMC article.
Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.
van den Bijgaart RJE, Kroesen M, Wassink M, Brok IC, Kers-Rebel ED, Boon L, Heise T, van Scherpenzeel M, Lefeber DJ, Boltje TJ, den Brok MH, Hoogerbrugge PM, Büll C, Adema GJ.
van den Bijgaart RJE, et al. Among authors: brok ic.
J Biol Chem. 2019 Mar 22;294(12):4437-4449. doi: 10.1074/jbc.RA118.002763. Epub 2019 Jan 22.
J Biol Chem. 2019.
PMID: 30670592
Free PMC article.
Item in Clipboard
Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma.
Kroesen M, Büll C, Gielen PR, Brok IC, Armandari I, Wassink M, Looman MW, Boon L, den Brok MH, Hoogerbrugge PM, Adema GJ.
Kroesen M, et al. Among authors: brok ic.
Oncoimmunology. 2016 Mar 28;5(6):e1164919. doi: 10.1080/2162402X.2016.1164919. eCollection 2016 Jun.
Oncoimmunology. 2016.
PMID: 27471639
Free PMC article.
Item in Clipboard
Effector γδ T Cell Differentiation Relies on Master but Not Auxiliary Th Cell Transcription Factors.
Barros-Martins J, Schmolka N, Fontinha D, Pires de Miranda M, Simas JP, Brok I, Ferreira C, Veldhoen M, Silva-Santos B, Serre K.
Barros-Martins J, et al. Among authors: brok i.
J Immunol. 2016 May 1;196(9):3642-52. doi: 10.4049/jimmunol.1501921. Epub 2016 Mar 18.
J Immunol. 2016.
PMID: 26994218
Item in Clipboard
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents.
Kroesen M, Brok IC, Reijnen D, van Hout-Kuijer MA, Zeelenberg IS, Den Brok MH, Hoogerbrugge PM, Adema GJ.
Kroesen M, et al. Among authors: brok ic.
Cancer Immunol Immunother. 2015 May;64(5):563-72. doi: 10.1007/s00262-015-1663-y. Epub 2015 Feb 17.
Cancer Immunol Immunother. 2015.
PMID: 25687736
Free PMC article.
Item in Clipboard
HDAC inhibitors and immunotherapy; a double edged sword?
Kroesen M, Gielen P, Brok IC, Armandari I, Hoogerbrugge PM, Adema GJ.
Kroesen M, et al. Among authors: brok ic.
Oncotarget. 2014 Aug 30;5(16):6558-72. doi: 10.18632/oncotarget.2289.
Oncotarget. 2014.
PMID: 25115382
Free PMC article.
Review.
Item in Clipboard
Cite
Cite